LaBarre Michael J.
SEC CIK 1507174 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | SVP, Chief Technical Off | 173.8K | — | $20.24M | 73 | 2021-07-01 | 2025-02-25 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
LaBarre Michael J. made no open-market trades at HALO in the last 12 months.
Transactions 73
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-27 | 2025-02-25+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale | $58.10 | -21.7K | 173.8K | -11% | -$1.26M |
| D | 2025-02-24 | 2025-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $57.75 | -2,410 | 195.5K | -1% | -$139.2K |
| D | 2025-02-24 | 2025-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +4,747 | 197.9K | +2% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +34.7K | 194.1K | +22% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $58.29 | -15.3K | 191.0K | -7% | -$891.4K |
| DM | 2024-10-16 | 2024-10-15+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $19.06 | +20.0K | 183.8K | +12% | +$381.3K |
| DM | 2024-10-16 | 2024-10-15+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $53.50 | -20.0K | 173.8K | -10% | -$1.07M |
| DM | 2024-09-18 | 2024-09-17+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $16.65 | +20.0K | 183.8K | +12% | +$333.0K |
| DM | 2024-09-18 | 2024-09-17+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $62.46 | -20.0K | 175.8K | -10% | -$1.25M |
| D | 2024-08-27 | 2024-08-27 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $18.41 | +5,580 | 173.8K | +3% | +$102.7K |
| DM | 2024-08-21 | 2024-08-20+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $61.40 | -20.0K | 168.2K | -11% | -$1.23M |
| DM | 2024-08-21 | 2024-08-20+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $16.65 | +20.0K | 178.2K | +13% | +$333.0K |
| DM | 2024-07-24 | 2024-07-23+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $11.65 | +20.0K | 178.2K | +13% | +$233.0K |
| DM | 2024-07-24 | 2024-07-23+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $55.00 | -20.0K | 168.2K | -11% | -$1.10M |
| D | 2024-06-20 | 2024-06-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $49.43 | -10.0K | 168.2K | -6% | -$494.3K |
| D | 2024-06-20 | 2024-06-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $8.11 | +10.0K | 178.2K | +6% | +$81.1K |
| DM | 2024-05-22 | 2024-05-21+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $8.11 | +20.0K | 178.2K | +13% | +$162.2K |
| DM | 2024-05-22 | 2024-05-21+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $45.27 | -20.0K | 168.2K | -11% | -$905.4K |
| DM | 2024-04-17 | 2024-04-16+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $8.11 | +20.0K | 178.2K | +13% | +$162.2K |
| DM | 2024-04-17 | 2024-04-16+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $38.42 | -20.0K | 168.2K | -11% | -$768.4K |
| DM | 2024-03-26 | 2024-03-26 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $11.20 | +11.6K | 165.3K | +8% | +$130.2K |
| DM | 2024-03-13 | 2024-03-12+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $41.95 | -20.0K | 156.6K | -11% | -$839.1K |
| DM | 2024-03-13 | 2024-03-12+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $11.37 | +20.0K | 163.0K | +14% | +$227.3K |
| DM | 2024-02-28 | 2024-02-27+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $39.75 | -20.0K | 156.6K | -11% | -$795.0K |
| D | 2024-02-28 | 2024-02-28 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $8.11 | +7,471 | 164.0K | +5% | +$60.6K |
| DM | 2024-02-20 | 2024-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +10.4K | 171.2K | +6% | $0 |
| DM | 2024-02-20 | 2024-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $36.10 | -5,257 | 169.1K | -3% | -$189.8K |
| DM | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $35.91 | -5,040 | 164.0K | -3% | -$181.0K |
| D | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +3,386 | 160.5K | +2% | $0 |
| D | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | A - Grant | $0.00 | +8,479 | 167.8K | +5% | $0 |
| D | 2024-02-13 | 2024-02-10 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $35.49 | -2,901 | 157.1K | -2% | -$103.0K |
| D | 2024-02-13 | 2024-02-10 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +8,133 | 160.0K | +5% | $0 |
| DM | 2024-01-18 | 2024-01-16+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $12.07 | +20.0K | 161.9K | +14% | +$241.4K |
| DM | 2024-01-18 | 2024-01-16+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $36.00 | -20.0K | 151.9K | -12% | -$720.0K |
| DM | 2023-12-13 | 2023-12-12+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $12.81 | +20.0K | 161.9K | +14% | +$256.2K |
| DM | 2023-12-13 | 2023-12-12+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $40.01 | -20.0K | 152.6K | -12% | -$800.3K |
| DM | 2023-11-16 | 2023-11-14+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $39.44 | -20.0K | 151.9K | -12% | -$788.7K |
| DM | 2023-11-16 | 2023-11-14+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $14.06 | +20.0K | 161.9K | +14% | +$281.3K |
| D | 2023-10-17 | 2023-10-17 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $19.98 | +10.0K | 161.9K | +7% | +$199.8K |
| D | 2023-10-17 | 2023-10-17 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $36.52 | -10.0K | 151.9K | -6% | -$365.2K |
| D | 2023-09-19 | 2023-09-19 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $19.98 | +10.0K | 161.9K | +7% | +$199.8K |
| D | 2023-09-19 | 2023-09-19 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $39.10 | -10.0K | 151.9K | -6% | -$391.0K |
| DM | 2023-08-23 | 2023-08-22 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $19.68 | +10.0K | 153.8K | +7% | +$196.8K |
| DM | 2023-08-23 | 2023-08-22 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $42.41 | -10.0K | 151.9K | -6% | -$424.1K |
| DM | 2023-07-19 | 2023-07-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $15.30 | +20.0K | 151.9K | +15% | +$306.1K |
| D | 2023-07-19 | 2023-07-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $40.43 | -10.0K | 141.9K | -7% | -$404.3K |
| D | 2023-06-22 | 2023-06-21 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $36.00 | -10.0K | 141.9K | -7% | -$360.0K |
| D | 2023-06-22 | 2023-06-21 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $18.41 | +10.0K | 151.9K | +7% | +$184.1K |
| D | 2023-04-19 | 2023-04-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $18.41 | +10.0K | 151.9K | +7% | +$184.1K |
| D | 2023-04-19 | 2023-04-18 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $36.00 | -10.0K | 141.9K | -7% | -$360.0K |
| DA | 2023-04-19 | 2023-02-27 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $49.55 | -2,984 | 141.9K | -2% | -$147.9K |
| DA | 2023-04-19 | 2023-02-27 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $18.41 | +2,984 | 144.9K | +2% | +$54.9K |
| M | 2023-02-28 | 2023-02-27 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale | $49.55 | -10.0K | 138.9K | -7% | -$495.5K |
| D | 2023-02-21 | 2023-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +6,112 | 151.8K | +4% | $0 |
| D | 2023-02-21 | 2023-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $49.26 | -2,878 | 148.9K | -2% | -$141.8K |
| D | 2023-02-17 | 2023-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +3,386 | 146.9K | +2% | $0 |
| D | 2023-02-17 | 2023-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $49.20 | -1,170 | 145.7K | -0.8% | -$57.6K |
| D | 2023-02-17 | 2023-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $48.39 | -10.0K | 143.5K | -7% | -$483.9K |
| DM | 2023-02-14 | 2023-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $48.92 | -5,676 | 148.3K | -4% | -$277.7K |
| DM | 2023-02-14 | 2023-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +16.0K | 151.3K | +12% | $0 |
| M | 2023-01-18 | 2023-01-17 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale | $50.46 | -10.0K | 143.1K | -7% | -$504.6K |
| M | 2022-12-13 | 2022-12-13 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale | $58.66 | -10.0K | 153.1K | -6% | -$586.6K |
| M | 2022-11-16 | 2022-11-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale | $54.13 | -10.0K | 166.3K | -6% | -$541.3K |
| D | 2022-02-17 | 2022-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $0.00 | +3,386 | 174.3K | +2% | $0 |
| D | 2022-02-17 | 2022-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | F - Tax | $34.43 | -1,170 | 173.1K | -0.7% | -$40.3K |
| DM | 2022-02-14 | 2022-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | F - Tax | $34.34 | -7,712 | 162.0K | -5% | -$264.8K |
| DM | 2022-02-14 | 2022-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $0.00 | +21.8K | 169.9K | +15% | $0 |
| D | 2021-10-12 | 2021-10-12 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $13.10 | +8,050 | 156.8K | +5% | +$105.5K |
| D | 2021-10-01 | 2021-10-01 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | S - Sale+OE | $39.93 | -29.4K | 148.8K | -17% | -$1.18M |
| D | 2021-10-01 | 2021-10-01 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $13.10 | +29.4K | 178.2K | +20% | +$385.8K |
| D | 2021-07-15 | 2021-07-15 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $6.55 | +14.7K | 148.8K | +11% | +$96.2K |
| D | 2021-07-06 | 2021-07-01 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | S - Sale+OE | $45.70 | -40.3K | 134.1K | -23% | -$1.84M |
| D | 2021-07-06 | 2021-07-01 | HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $6.55 | +40.3K | 174.4K | +30% | +$264.1K |
Purchase Sale Sale after option exercise All abbreviations